- Hudes G, Carducci M, Tomczak P, et al. Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. N Engl J Med. 2007;356(22):2271-2281.
- Referenced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Kidney Cancer V.2.2019. © National Comprehensive Cancer Network, Inc 2018. All rights reserved. Accessed September 17, 2018. To view the most recent and complete version of the guideline, go online to www.nccn.org.